| 0 (0%) | 04-26 03:14 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 27.93 | 1-year : | 28.9 |
| Resists | First : | 23.91 | Second : | 24.75 |
| Pivot price | 23.57  |
|||
| Supports | First : | 22.55 | Second : | 18.76 |
| MAs | MA(5) : | 23.29 |
MA(20) : | 23.73 |
| MA(100) : | 23.37 |
MA(250) : | 22.61 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 43 |
D(3) : | 38.6 |
| RSI | RSI(14): 45.7 |
|||
| 52-week | High : | 30.38 | Low : | 19.02 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PHI ] has closed above bottom band by 37.4%. Bollinger Bands are 23.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 23.64 - 23.79 | 23.79 - 23.89 |
| Low: | 22.77 - 22.95 | 22.95 - 23.08 |
| Close: | 23.06 - 23.33 | 23.33 - 23.52 |
Wed, 17 Apr 2024
Ophelia Dahl Named to TIME100 List - Partners in Health
Tue, 26 Mar 2024
Fostering Cross-Site Collaboration: Insights from the PIH Americas Regional Workshop - Partners in Health
Tue, 05 Mar 2024
Remembering Dr. Howard Hiatt, A PIH Mentor and Global Health Champion - Partners in Health
Wed, 14 Feb 2024
PIH Health, Medline expand prime vendor partnership to service all points of care - PR Newswire
Fri, 26 Jan 2024
Social Medicine: What Is It and Why Does It Matter? - Partners in Health
Thu, 11 Jan 2024
Opinion | Epitome? Pity me, I thought it was pronounced eh-pih-tome. - The Washington Post
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 216 (M) |
| Shares Float | 78 (M) |
| Held by Insiders | 3.9 (%) |
| Held by Institutions | 3 (%) |
| Shares Short | 719 (K) |
| Shares Short P.Month | 174 (K) |
| EPS | 2.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 484.63 |
| Profit Margin | 12.6 % |
| Operating Margin | 1.9 % |
| Return on Assets (ttm) | 4.3 % |
| Return on Equity (ttm) | 23.9 % |
| Qtrly Rev. Growth | 4.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 976.34 |
| EBITDA (p.s.) | 415.53 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 85,760 (M) |
| Levered Free Cash Flow | -23,000 (M) |
| PE Ratio | 10.88 |
| PEG Ratio | 0 |
| Price to Book value | 0.04 |
| Price to Sales | 0.02 |
| Price to Cash Flow | 0.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|